SCHEMBL4183479

SCHEMBL4183479

CCCC(N1CCN(C(CCC)S(=O)(=O)O)CC1)S(=O)(=O)O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 6/20 0.34
HDAC1 Q13547 3/20 0.34
HDAC2 Q92769 3/20 0.34
CHRM1 P11229 1/20 0.34
AKR1A1 P14550 1/20 0.34
CHRM3 P20309 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
ADRA1A P35348 1/20 0.34
HRH1 P35367 1/20 0.34
DRD3 P35462 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
HDAC7 Q8WUI4 3/20 0.33
HDAC8 Q9BY41 3/20 0.33
HDAC6 Q9UBN7 3/20 0.33
HDAC9 Q9UKV0 3/20 0.33
HDAC5 Q9UQL6 3/20 0.33
HDAC3 O15379 2/20 0.33
HDAC4 P56524 2/20 0.33
HDAC10 Q969S8 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1486106 0.90 SLC6A3 (0.38) SLC6A3NPSR1SLC6A2SLC6A4
SCHEMBL3691589 0.87 TSHR (0.41) TSHRNPSR1
SCHEMBL435752 0.87 SIGMAR1 (0.38) CHRM1CHRM3CYP3A4TSHRNFKB1
SCHEMBL129496 0.86 CHRM2 (0.40) CHRM1TSHRNPSR1TP53
SCHEMBL3414469 0.85 CHRM2 (0.39) CHRM1TSHRNPSR1TP53
SCHEMBL2586827 0.82
SCHEMBL21832231 0.81 USP2 (0.33) DRD3TSHR
SCHEMBL28408206 0.80
SCHEMBL28919120 0.79 SORD (0.36) HTR2A
Water SCHEMBL29151581 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230279290-A1 COMPOSITIONS AND METHODS FOR ASSAY MEASUREMENTS MESO SCALE TECHNOLOGIES LLC (US) 2023-09-07 US claimed
US-20210109100-A1 KITS SUITABLE FOR USE IN ELECTROCHEMILUMINESCENCE METHODS AND METHODS OF EFFECTING A SPECIFIC-BINDING NON-WASH ASSAY MESO SCALE TECHNOLOGIES, LLC. (US) 2021-04-15 US claimed
US-10753934-B2 Kits suitable for use in electrochemiluminescence methods and methods of effecting a specific-binding non-wash assay MESO SCALE TECHNOLOGIES, LLC. (US) 2020-08-25 US claimed
EP-1893990-A2 ELECTROCHEMISTRY AND ELECTROGENERATED CHEMILUMINESCENCE WITH A SINGLE FARADAIC ELECTRODE THE UNIVERSITY OF TEXAS SYSTEM (US) 2008-03-05 EP claimed
EP-1436598-A4 ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME MESO SCALE TECHNOLOGIES LLC (US) 2007-10-31 EP claimed
WO-2007053191-A9 ELECTROCHEMISTRY AND ELECTROGENERATED CHEMILUMINESCENCE WITH A SINGLE FARADAIC ELECTRODE UNIV TEXAS (US) 2007-08-09 WO claimed
WO-2007053191-A2 ELECTROCHEMISTRY AND ELECTROGENERATED CHEMILUMINESCENCE WITH A SINGLE FARADAIC ELECTRODE UNIVERSITY OF TEXAS SYSTEM (US) 2007-05-10 WO claimed
US-6919173-B2 Electrochemiluminescence; kinases; phosphatases MESO SCALE TECHNOLOGIES, LLC. (US) 2005-07-19 US claimed
EP-1436598-A1 ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME Meso Scale Technologies LLC (US) 2004-07-14 EP claimed
US-20030175803-A1 Electrochemiluminescence; kinases; phosphatases MESO SCALE TECHNOLOGIES, LLC. 2003-09-18 US claimed
WO-2003023380-A1 ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME MESO SCALE TECHNOLOGIES, LLC (US) 2003-03-20 WO claimed
US-20230279290-A1 COMPOSITIONS AND METHODS FOR ASSAY MEASUREMENTS MESO SCALE TECHNOLOGIES LLC (US) 2023-09-07 US disclosed
US-20210109100-A1 KITS SUITABLE FOR USE IN ELECTROCHEMILUMINESCENCE METHODS AND METHODS OF EFFECTING A SPECIFIC-BINDING NON-WASH ASSAY MESO SCALE TECHNOLOGIES, LLC. (US) 2021-04-15 US disclosed
US-10753934-B2 Kits suitable for use in electrochemiluminescence methods and methods of effecting a specific-binding non-wash assay MESO SCALE TECHNOLOGIES, LLC. (US) 2020-08-25 US disclosed
US-20180238882-A1 KITS SUITABLE FOR USE IN ELECTROCHEMILUMINESCENCE METHODS AND METHODS OF EFFECTING A SPECIFIC-BINDING NON-WASH ASSAY MESO SCALE TECHNOLOGIES, LLC. (US) 2018-08-23 US disclosed
US-20050136048-A1 Electrochemiluminescence assays; aqueous reagent composition consisting of water, tripropylamine 50 mM-1000 mM and an electrolyte comprising a pH buffer selected from tris(hydroxymethyl)aminomethane and glycylglycine, pH of 6.5-8.5; improved sensitivity MESO SCALE TECHNOLOGIES, LLC. 2005-06-23 US disclosed
US-20050136497-A1 Comprisese water, piperazine-N,N'-bis(2-ethanesulfonic acid), electrolyte comprising buffer selected from tris(hydroxymethyl)aminomethane, glycylglycine and phosphate, phenyl ether-containing surfactant, and optionally preservative; electroluminescence MESO SCALE TECHNOLOGIES, LLC. 2005-06-23 US disclosed
EP-1436598-A1 ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME Meso Scale Technologies LLC (US) 2004-07-14 EP disclosed
US-20030175803-A1 Electrochemiluminescence; kinases; phosphatases MESO SCALE TECHNOLOGIES, LLC. 2003-09-18 US disclosed
WO-2003023380-A1 ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME MESO SCALE TECHNOLOGIES, LLC (US) 2003-03-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050136048-A1 Electrochemiluminescence assays; aqueous reagent composition consisting of water, tripropylamine 50 mM-1000 mM and an electrolyte comprising a pH buffer selected from tris(hydroxymethyl)aminomethane and glycylglycine, pH of 6.5-8.5; improved sensitivity GNMT, TET1, MPG SLC6A3 734/4885HDAC1 4879/4885HDAC2 4872/4885
US-20030175803-A1 Electrochemiluminescence; kinases; phosphatases PRKACA, DUSP3, PPP6C SLC6A3 4258/4885HDAC1 4285/4885HDAC2 4400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.